Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation
Yanxin Fan, Marta Murgia, Monika I. Linder, Yoko Mizoguchi, Cong Wang, Marcin Łyszkiewicz, Natalia Ziȩtara, Yanshan Liu, Stephanie Frenz, Gabriela Sciuccati, Armando Partida-Gaytan, Zahra Alizadeh, Nima Rezaei, Peter Rehling, Sven Dennerlein, Matthias Mann, Christoph Klein
Yanxin Fan, Marta Murgia, Monika I. Linder, Yoko Mizoguchi, Cong Wang, Marcin Łyszkiewicz, Natalia Ziȩtara, Yanshan Liu, Stephanie Frenz, Gabriela Sciuccati, Armando Partida-Gaytan, Zahra Alizadeh, Nima Rezaei, Peter Rehling, Sven Dennerlein, Matthias Mann, Christoph Klein
View: Text | PDF
Research Article Cell biology Immunology

HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation

  • Text
  • PDF
Abstract

The relevance of molecular mechanisms governing mitochondrial proteostasis to the differentiation and function of hematopoietic and immune cells is largely elusive. Through dissection of the network of proteins related to HCLS1-associated protein X-1, we defined a potentially novel functional CLPB/HAX1/(PRKD2)/HSP27 axis with critical importance for the differentiation of neutrophil granulocytes and, thus, elucidated molecular and metabolic mechanisms underlying congenital neutropenia in patients with HAX1 deficiency as well as bi- and monoallelic mutations in CLPB. As shown by stable isotope labeling by amino acids in cell culture (SILAC) proteomics, CLPB and HAX1 control the balance of mitochondrial protein synthesis and persistence crucial for proper mitochondrial function. Impaired mitochondrial protein dynamics are associated with decreased abundance of the serine-threonine kinase PRKD2 and HSP27 phosphorylated on serines 78 and 82. Cellular defects in HAX1–/– cells can be functionally reconstituted by HSP27. Thus, mitochondrial proteostasis emerges as a critical molecular and metabolic mechanism governing the differentiation and function of neutrophil granulocytes.

Authors

Yanxin Fan, Marta Murgia, Monika I. Linder, Yoko Mizoguchi, Cong Wang, Marcin Łyszkiewicz, Natalia Ziȩtara, Yanshan Liu, Stephanie Frenz, Gabriela Sciuccati, Armando Partida-Gaytan, Zahra Alizadeh, Nima Rezaei, Peter Rehling, Sven Dennerlein, Matthias Mann, Christoph Klein

×

Figure 7

HSP27 overexpression restores neutrophil differentiation defect in HAX1–/– iPSCs.

Options: View larger image (or click on image) Download as PowerPoint
HSP27 overexpression restores neutrophil differentiation defect in HAX1–...
(A) Immunoblot analysis of WT and HAX1-deficient iPSCs overexpressing either HSP27 or HAX1. *An additional band detected by the HSP27 antibody after HSP27 overexpression in iPSCs. (B) Live floating cells generated from indicated iPSC colonies (6 per well) were quantified during differentiation (n = 3, *P < 0.05, 2-way ANOVA followed by Tukey’s test). (C) Light microscopy of iPSC-derived immature and mature neutrophil granulocytes (at day 28) stained with May-Grünwald Giemsa. Scale bar: 10 μm. (D) Quantification of the distribution of immature (myeloblasts, promyelocytes, myelocytes, and metamyelocytes) and mature neutrophil granulocytes (band and segmented neutrophils). (E and F) Analysis of differentiated neutrophil-like cells on day 28 by FACS (E) and quantification of immature iPSC-derived neutrophil granulocytes (mCherry+CD11b+CD33lo) (F) (n = 5, *P < 0.05, 1-way ANOVA followed by Tukey’s test). (G) Measurement of oxygen consumption rate (OCR) in hematopoietic progenitor cells derived from the indicated genotypes (at day 18 of iPSC-derived neutrophil granulocyte differentiation) following a sequential addition of oligomycin, FCCP, and rotenone (Rot) and antimycin A (AA). (H) Measurement of MMP in CD11b+CD33lo populations derived from WT, HAX1–/–, HAX1–/– + HAX1, or HAX1–/– + HSP27 iPSCs using DiOC6. (I) Quantification of the distribution of precursor populations in iPSC-derived myeloid cells from the indicated genotypes. Data represent 2 independent experiments. (J) Analysis of differentiated neutrophil-like cells (CD11b+CD33lo) at day 28 of differentiation by FACS. Data represent 3 independent experiments. (K) Measurement of OCR in hematopoietic progenitor cells derived from the indicated genotypes (at day 18 of iPSC-derived neutrophil granulocyte differentiation) following a sequential addition of oligomycin, FCCP, and Rot and AA. (L) Measurement of MMP in CD11b+CD33lo populations derived from WT, HAX1–/–, or HAX1–/–HSP27-2E iPSCs using DiOC6 at day 28 of differentiation. Data represent 3 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts